Background: Caloric restriction (CR) increases both average and maximum lifespan, retards physiological signs of ageing, and delays the onset of several diseases and may mediate neuropathic pain. Neuropathic pain seriously affects the quality of life of patients. In this study, we investigated whether CR exerts anti-nociceptive effects on neuropathic pain, and probed its potential mechanisms. Methods: Adult rats were divided into two dietary groups: an ad libitum (AL)-fed group and a CR group, which was provided with 60% of the food intake of AL rats for 6 weeks. The effects of 6-week CR on pain behaviour and neuroinflammation induced by chronic constriction injury of the sciatic nerve were evaluated. Results: Rats subjected to a CR diet had reduced hypersensitivity to mechanical and thermal stimuli after nerveconstriction injury. CR increased the silent information regulator 1 (SIRT1) expression, and suppressed the nerveconstriction-induced production of mitochondrial-derived reactive oxygen species and activation of nuclear factor kappa B accompanied by suppression of mature interleukin-1b production in the ipsilateral spinal cord dorsal horn. The inhibition of SIRT1 reversed the effects of caloric restriction on pain behaviours. Moreover, CR decreased the phosphorylation of N-methyl-D-aspartate receptor subunits and the mitogen-activated protein kinase family, decreased the sensory neurone excitability, and inhibited the nerve-constriction-induced glial-cell activation. Conclusions: These results suggest that the effects of CR on pain behaviours in a rat model of nerve injury are via inhibition of excessive neuro-inflammation induced by the injury. CR may be of benefit in patients with neuropathic pain.
Caloric restriction (CR) refers to a dietary regimen low in total calories, but containing essential components at a normal level in order to avoid malnutrition. 1 This dietary regimen has several beneficial effects, including increased lifespan, improved quality of life, and delayed physiological signs of ageing.
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Neuro-inflammation is mainly involved in nerve-injuryinduced neuropathic pain. 4 Interleukin-1b (IL-1b), a gatekeeper of inflammation in hyperalgesia, 5 plays an important role in the onset and maintenance of chronic-constrictioninjury (CCI)-induced neuropathic pain. 4, 6 Increased IL-1b expression in the spinal cord correlates with the persistence of hyperalgesia and allodynia observed in CCI models. 4, 6 Acetylation of nuclear factor kappa B (NFkB)dwhich is responsible for the transcription of pro-IL-1b 7 dand the activation of the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome caspase-1 platformdwhich is responsible for the maturation of IL-1bdare both involved in CCI-induced neuropathic pain. 8 Short-term and intermittent food deprivation, a dietary regime that induces a physiological state different from that of CR, reduces hyperalgesia in laboratory rodents. 9 ,10 Recent studies have indicated that CR attenuates neuro-inflammation mainly by up-regulating the expression of silent information regulator 1 (SIRT1), a class III histone deacetylase (HDAC), thus inactivating NFkB, 11 which is responsible for the transcription of a wide cascade of cytokines and proteins, including IL-1b 7 and NLRP3. 12 In addition, CR improves mitochondrial function through deacetylation and activation of peroxisome-proliferator-activated receptor gamma coactivator 1a (PGC1a) 13 by SIRT1. 14 PGC1a plays a key role in regulating mitochondrial fusion/fission and reactive oxygen species (ROS) scavenging by modulating the expression and activity of mitofusin-2 (Mfn2), dynamin-related protein 1 (DRP1), 15, 16 and manganese superoxide dismutase (Mn-SOD). 17, 18 It has been suggested that mitochondrial dysfunction and increased production of mitochondria-derived ROS might contribute to central sensitization in neuropathic pain 19 through the direct activation of NLRP3 inflammasomes. 20 However, so far, there has been no direct evidence from clinical or experimental studies regarding the effect of CR on neuropathic pain. Therefore, we investigated whether CR exerts anti-nociceptive effects on neuropathic pain induced by CCI of the sciatic nerve in adult rats, and probed the potential mechanisms of these effects.
Methods

Animals
Adult male SpragueeDawley rats, weighing 240e260 g, were provided by the Laboratory Animal Center of the Affiliated Nanjing Drum Tower Hospital. All rats were housed in individual clear cages in a climate-controlled room (20e24 C), with a 12 h light cycle starting at 06:00 h. All newly arrived rats were provided ad libitum (AL) access to food and water for 1 week of acclimation before the commencement of experimental procedures. The experimental procedures were approved by the Institutional Animal Care and Use Committee of Nanjing University, and are reported in accordance with relevant aspects of the Animal Research: Reporting of In Vivo Experiments guidelines. Rats were randomly allocated to treatment groups in accordance with a random number table.
At the end of the experiments, rats were culled by cervical dislocation under anaesthesia.
Dietary regimen
A standard regimen was applied for CR. 21 Both control and CR rats received the same commercial laboratory pellets (Xietong Feed Co., Jiangsu, China), the composition of which is presented in Supplementary Material Table S1 . Rats in Group AL were fed AL, and the daily food intake was consistent across the experimental period (25e35 g day À1 ).
Rats in Group CR received 60% of the quantity of food consumed by the rats in Group AL. To avoid malnutrition, vitamin and mineral mixtures were added to the diet in Group CR to make the dietary micronutrient content identical to that in Group AL; however, the final caloric content of the diet in Group CR was 40% lower than that in Group AL. Food was weighed and provided to the animals in Group CR daily, approximately 1 h before the start of the dark cycle. The dietary regimens were started after 1 week of acclimatization and continued throughout the experimental period. During this period, body weight and Lee's index (cube root of body weight in grammes divided by nose-to-anus length in centimetres) were regularly noted.
Surgery for CCI
The rats were anaesthetized with sodium pentobarbital (40 mg kg À1 ; intraperitoneal injection; Sigma-Aldrich, St Louis, MO, USA), and adequate anaesthesia was ascertained by the lack of response to a nociceptive stimulus. A rescueanalgesia protocol was in place, which involved sevoflurane administration when the anaesthesia depth or duration was determined to be inadequate. The right common sciatic nerve was exposed at the level of the mid-thigh by blunt dissection through the biceps femoris. Proximal to the point of trifurcation of the sciatic nerve, about 7 mm of nerve was dissected, and four ligatures (4-0 Chromic Gut; Ethicon, Rome, Italy) were made loosely around the nerve, with a spacing of approximately 1 mm between ligatures. The wound was closed in layers. In sham rats, identical dissection and exposure procedures were performed, but the sciatic nerve was not ligated. 22 
Locomotor activity
Locomotor responses under non-stressful conditions were assessed using a Plexiglas locomotor activity box (100 Â 100 Â 20 cm; Tianqi, Shanghai, China) in a darkened room. 23 Eight infrared beams in an XeY matrixd4.5 cm off the ground and 20 cm apartdwere counted when broken. Locomotor activity was indicated as the number of beams broken per minute. The experimenters were blinded to the study design and grouping for treatment.
Editor's key points
Caloric restriction increases longevity in animals, and there is some evidence it may benefit pain. In rats with experimental nerve injury, 6 weeks of caloric restriction improved pain measures with no effects on motor activity. Neuro-inflammatory signalling pathways were shown to be involved. Caloric restriction does not affect physiological functioning, is easy to implement and cheap, and may be useful in patients with neuropathic pain.
Pain behaviour
Behavioural tests were administered between 11:00 and 15:00 h, in order to minimize any possible influence from the satiety effect of recent feeding and the potential reward of feeding soon after the behavioural test. Before each test, the rats were allowed to acclimatize for 30 min. Behavioural responses were measured by experimenters who were blinded to the study design and grouping for treatment.
Mechanical allodynia
Mechanical allodynia was assessed using the Dynamic Plantar Aesthesiometer (Ugo Basile, Varese, Italy). Rats were placed in transparent Plexiglas compartments (20 Â 25 Â 15 cm) on a metal mesh floor (n¼8). A touch probe (filament) of nickeletitanium alloy was pressed vertically against the central plantar surface, and the force was increased uniformly. A positive response was defined by flinching or withdrawal of the hind paw. The test was repeated five times with a 5 min interval between tests. Paw withdrawal mechanical threshold was recorded as the tolerance level in grammes.
Thermal hyperalgesia
Thermal hyperalgesia to radiant heat was determined using an automatic Plantar Test apparatus (Ugo Basile). Rats were placed in clear plastic cages on an elevated glass plate (n¼8). The movable heat stimulator was moved to focus heat on the central plantar surface of the hind paw through the glass plate. Nociceptive end points were defined by the characteristic lifting or licking of the hind paw, and the time to end point was considered as the paw withdrawal thermal latency. A cut-off time of 25 s was used to avoid tissue damage. Five trials were undertaken per rat, with a 5 min interval between trials.
Drug preparation and intrathecal injection
The selective SIRT1 inhibitor, EX 527 (Selisistat; Selleck Chemicals, Houston, TX, USA), was dissolved in dimethyl sulphoxide (DMSO) 10% to a concentration of 1.2 mM. Under sevoflurane 2.5% anaesthesia, rats received a single intrathecal injection of either EX 527, or a vehicle (10% DMSO) in a volume of 10 ml was administered, into the L4e5 intervertebral space on Day 7 after surgery. 24 The dose was selected in accordance with the findings of a previous report 25 and the results of our preliminary experiments.
Other methods
The methods for western blotting, immunoprecipitation, superoxide-dismutase-activity assays, ROS detection, caspase-1 activity assay, and immunofluorescence staining are presented in Supplementary Material.
Statistical analysis
Statistical analysis was undertaken using SPSS 20.0 (SPSS, Inc., Chicago, IL, USA). Data regarding body weight, Lee's index, motor activity, and pain behaviour were expressed as mean (standard deviation) and analysed by two-way repeated measures analysis of variance (treatment Â time) followed by Bonferroni post hoc testing as appropriate. Data from western blotting, immunofluorescence assays, and enzyme-activity assays are presented as individual raw data points, with KruskaleWallis testing. P<0.05 was considered statistically significant.
Results
Body weight, Lee's index, and motor activity CR led to a significant decrease in body weight, which eventually stabilized at approximately 70% of the body weight of AL rats (450e550 g at the end of the experiment, P<0.05; Fig. 1a) . CR but not AL rats exhibited a significant decrease in Lee's index over the duration of CR (P<0.05, Fig. 1b) . After the 10-week dietary regimen, there were no significant differences in the serum levels of biochemical indicators between Groups AL and CR (Supplementary Material Table S2 ). The motor activity in CR rats under non-stressful conditions was similar to that of AL rats before and after a 6-week dietary regimen (Fig. 1c) .
Mechanical allodynia and thermal hyperalgesia and SIRT1
Surgery for CCI was performed after 6 weeks after the initiation of the dietary regimen. No rats died or developed paralysis, and the rescue protocol was not implemented. Responses to mechanical or thermal stimuli were not different between the treatment groups before surgery or between shamoperated animals regardless of diet. After CCI, the withdrawal thresholds to both thermal and mechanical stimuli were lower compared with sham groups in both AL and CR rats. The withdrawal thresholds were significantly higher between Days 3 and 28 after CCI in rats receiving the CR diet compared with the AL diet ( Fig. 2a and b) .
SIRT1 expression was higher in CResham rats than ALesham rats in the ipsilateral spinal cord dorsal horn on Day 7 after surgery ( Fig. 2c and d) , and was significantly decreased in both groups of rats after CCI compared with the sham animals ( Fig. 2c and d) . However, SIRT1 expression in the CR rats after CCI was higher than in AL rats after CCI ( Fig. 2c and d) . The inhibition of SIRT1 by EX 527 administration reversed the CR-induced changes in withdrawal thresholds to both mechanical and thermal stimuli after CCI, and this effect lasted for approximately 4 h (Fig. 2e and f) .
PGC1a and mitochondria-derived ROS
CCI resulted in decreased PGC1a expression with increased PGC1a acetylation in both AL and CR rats. However, the animals on the CR diet had a markedly higher PGC1a expression and a lower PGC1a acetylation in both sham and CCI rats ( Fig. 3c and d) . The expression of Mfn2 was higher and DRP1 was lower in CR than AL rats after CCI (Fig. 3e and f) . Both cytosolic and mitochondrial superoxide dismutase [copper/ zinc superoxide dismutase (Cu/Zn-SOD) and Mn-SOD, respectively] activity and expression were markedly increased in CR rats after CCI than in AR rats, or sham rats (Fig. 3gej) . The production of mitochondria-derived ROS was correspondingly significantly lower in the CR rats after CCI than in the AL rats ( Fig. 3b and k) . surgery in the rats receiving either of the diets (Figs 4e6), which were consistently lower in CR rats.
Discussion
The major findings of the present study was that 6 weeks of CR in adult rats reduced mechanical allodynia and thermal hyperalgesia after a chronic nerve-constriction injury, and this was mediated by SIRT1 and attenuation of neuroinflammation. These findings have relevance for the antinociceptive effects of CR.
Pathogenesis and maintenance of neuropathic pain involve not only increased neuronal excitability, but also interactions between neurones and inflammatory immune cells, and inflammatory cytokines. 26 In response to nervous-tissue damage, resident or recruited immune cells are activated; these produce abundant inflammatory mediators, including IL-1b, tumour necrosis factor-alpha (TNF-a), and IL-6 in the spinal cord. 4 Activation of NFkB, a pleiotropic transcription factor, occurs in the spinal cord after surgery for CCI; it facilitates the synthesis and release of a wide range of cytokines, and has a pivotal role in neuro-inflammation. 27 The full transcriptional activation of NFkB requires its acetylation at lysine 310, which can be accomplished by HDACs p300/CREB-binding protein (CBP), 28 and deacetylation is accomplished by SIRT1. 29 In experimental neuropathic pain, the comparison between rats receiving sham surgery and surgery for CCI revealed that p300/ CBP and p300/CBP-associated factor (PCAF) expression were significantly increased, 30, 31 and SIRT1 expression was significantly decreased in the spinal cord. Consequently, p65 acetylation and activation were increased, leading to an increased expression of pro-inflammatory genes. 32 Inhibition of p300 by specific small-hairpin RNA 31 and activation of SIRT1 by the potent agonist resveratrol 25 attenuate neuropathic pain by promoting p65 deacetylation and inhibiting NFkB-induced transcription. Amongst the various target proteins regulated by NFkB, IL-1b is a strong inducer of other cytokines, including TNF-a, IL-6, and macrophage inflammatory protein-1. 33 Increased IL-1b levels in the spinal cord cause the activation of glial cells and the excitation of sensory neurones through IL-1 receptor type I (IL-1R1), and these responses correlate well with the persistence of hyperalgesia and allodynia in animals with CCI, indicating the role of IL-1b in the onset and maintenance of neuropathic pain. 4, 6 The formation of active IL-1b requires the cysteine protease caspase-1, which is regulated by NLRP3 inflammasomes; caspase-1 cleaves the precursor pro-IL-1b to its mature form. 34, 35 Transcription of NLRP3, which primes NLRP3 inflammasomes and activates caspase-1, is also dependent on the acetylation and activation of NFkB. 12 The inflammasomeecaspase-1 platform is responsible for IL-1b maturation; the activation of this platform in spinal astrocytes and neurones plays a role in CCIinduced neuropathic pain. 8 In addition, disturbances in mitochondrial dynamics (fission/fusion), 36 dysfunction in endogenous antioxidant systems, 37 and increased production of mitochondria-derived ROS 19 might contribute to central sensitization in neuropathic pain through the direct activation of NLRP3 inflammasomes. 20 Therefore, to evaluate CCI-induced neuro-inflammation, we analysed the expression levels of IL-1b, mitochondria-derived ROS, and associated proteins involved in modulating IL-1b transcription and maturation in the spinal cord. Our findings revealed down-regulation of SIRT1 expression, increased production of mitochondria-derived ROS, upregulation of p300/CBP and PCAF expression, and increased NFkB p65 acetylation and caspase-1 activity in the ipsilateral spinal-cord dorsal horn, accompanied by decreased withdrawal responses to mechanical and thermal stimuli after surgery for CCI in rats fed AL. A 6-week restriction of caloric intake resulted in increased SIRT1 expression, decreased production of mitochondria-derived ROS, and decreased NFkB p65 acetylation and caspase-1 activity, accompanied by decreased mature active IL-1b and improvement in CCI- AL, ad libitum; CCI, chronic constriction injury; CR, caloric restriction; SIRT1, silent information regulator 1. induced mechanical and thermal nociceptive sensitization. Similar to the present results, previous findings have revealed significant SIRT1 up-regulation in the cortex and hippocampus of mice on a CR diet, which was found to delay brain senescence and prevent neurodegeneration. 11, 38 CR also improves mitochondrial function by up-regulating the expression of PGC1a, 13 which in turn down-regulates DRP1 expression, upregulates Mfn2 expression, 16 and modulates the activity of Mn-SOD and Cu/Zn-SOD, 17, 18 thus decreasing ROS levels and oxidative stress. Additionally, CR reduces caspase-1 activity, and mediates a parallel reduction in IL-1b expression and maturation in the spinal cord and adipose tissues, preventing NLRP3-inflammasome-induced inflammatory diseases.
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Activation (phosphorylation) of mitogen-activated protein kinases (MAPKs) after nerve injury contributes to hypersensitivity in neuropathic pain. 40 The production of immune factors in glial cells also plays an important role in nociceptive transmission. 41 Our results show that CR inhibited the phosphorylation of MAPKs and CCI-induced activation of glial cells in the spinal dorsal horn. The activation of most microglial receptors results in p38 phosphorylation, which in turn results in the production and release of multiple inflammatory mediators. 42 c-Jun N-terminal kinase, which is persistently activated in the astrocytes of the spinal cord after nerve injury, contributes to the maintenance of central sensitization and mechanical allodynia. 43 In addition to glial cells, phosphorylation and activation of N-methyl-D-aspartate receptor (NMDAR) in spinal neurones also play a vital role in the synaptic plasticity and enhanced sensory responses observed after nerve injury. 44 The activation of NMDAR induces a Ca 2þ influx, which initiates intracellular cascade responses and, consequently, causes phosphorylation of downstream molecules, including protein kinase C-gamma (PKCg) and extracellular signal-regulated kinase (ERK), which in turn leads to further activation of NMDAR and initiation of prolonged enhancement of excitability in spinal-cord neurones. 44 Phosphorylation of ERK in spinal dorsal horn neurones has been proved to be nociceptive specific. 45 The processes mentioned earlier are considered to constitute the main neuronal and glial mechanisms of neuropathic pain. We found that CR decreased the phosphorylation of NMDAR subunits and MAPKs, reduced sensory neurone excitability, and inhibited CCI-induced glial activation. There are several limitations to the present study. Firstly, the sources of IL-1b production were not identified, and IL-1b is synthesized and released by many cell types, including microglia, astrocytes, neurones, and endothelial cells. 46 Cleaved mature IL-1b released by glial cells can bind to IL-1R1 on the cell surfaces of small-to medium-sized sensory neurones in the spinal cord to induce the activation of tyrosine kinases and, subsequently, PKC. 47 This process might directly influence nociceptive transmission after nerve injury. 47 Moreover, all cell types express the IL-1b signalling receptor, IL-1R1. Therefore, IL1b can activate glial cells directly through IL-1R1. 46 The effects include promotion of glial-cell proliferation, activation of MAPKs and NFkB, and release of secondary pro-inflammatory mediators. 48 In the present study, we found that CR inhibited the CCI-induced up-regulation of expression of IL-1b, which might have been produced by glial cells and neurones; CR then resulted in the inhibition of neuronal excitability and glial activation, probably because of the decrease in the activation of IL-1R1 signals, including phosphorylation of NMDAR, PKCg, and MAPKs. Secondly, we did not identify the specific CR-induced transcriptional-regulation mechanisms of SIRT1 or the cell types responsible for SIRT1 expression. Previous studies have suggested that CR up-regulates SIRT1 expression in neurones and exerts neuroprotective effects. 38 It also reduces the activation of both astrocytes and microglia, and suppresses excessive neuro-inflammation and damage. 49, 50 Overexpression or activation of SIRT1 can attenuate hyperalgesia through inhibition of glial activation in the spinal cord. 51 Therefore, it is reasonable to speculate that, similar to other cells, CR also up-regulates SIRT1 expression in glial cells through a fork-head-dependent pathway. 52 Moreover, CR appears to inhibit glial-cell activation mainly through two mechanisms: (i) direct increase of SIRT1 expression in glial cells with inhibition of IL-1b production; and (ii) decreased glial-cell activity as a result of the attenuation of signal processes mediated by IL-1R1 on glial-cell surfaces as a result of decreased IL-1b expression. Lastly, the downstream mechanisms of PKCg signalling were not investigated. Upon activation, PKCg directly interacts with and phosphorylates various substrates, including transient receptor potential ion channels, glutamate receptor subunit 4, g-aminobutyric acid receptors, and m-opioid receptors, which are all involved in the nociceptive process associated with peripheral inflammation or neuropathy. 53, 54 Previous studies have indicated that PKCg is activated by IL-1b through the phosphatidylcholine-specific phospholipase C pathway. 55 Therefore, we chose PKCg not only as an index of excitability of sensory neurones, but also as a downstream molecule of the IL-1R1 signalling pathway for evaluating the effects and mechanisms of CR. Meanwhile, a further study on the mechanisms of PKCg downstream signalling is underway in our laboratory.
In conclusion, neuropathic pain responses in rats can be attenuated by a period of reduced caloric intake. These effects might be attributable to the inhibition of CCI-induced neuroinflammation, probably through SIRT1-regulated NFkBeIL-1b signalling. These findings highlight a new aspect of pain treatment. CR in both humans and animals does not appear to affect normal biological function, and is non-invasive, inexpensive, and easily implemented in various settings. It may, therefore, be a useful tool in patients with neuropathic pain.
Further research is required to explore the associated mechanisms.
